Table 2.
Effective Ablation (n=31) |
Ineffective Ablation/Recurrence (n=9) |
P value | |
---|---|---|---|
Site of origin of PAP arrhythmias | 0.16 | ||
Left ventricle, n (%) | 23 (74) | 9 (100) | |
Anterolateral PAP, n | 9 | 4 | |
Posteromedial PAP, n | 16 | 5 | |
Right ventricle, n (%) | 8 (26) | 0 (0) | |
Anterolateral PAP, n | 4 | 0 | |
Posteromedial PAP, n | 4 | 0 | |
Septal muscle, n | 1 | 0 | |
Pleomorphic PVCs, n (%) | 26 (84) | 5 (56) | 0.17 |
Number of PVC morphology, n | 4±3 | 4±5 | 0.60 |
Inducibility of VT, n (%) | 4 (13) | 0 (0) | 0.56 |
PP at ablation site, n (%) | 15 (48) | 0 (0) | 0.02 |
S-QRS interval at ablation site | 30±14 | 26±4 | 0.50 |
Amplitude during sinus rhythm, mV | 1.3±0.9 | 1.0±0.6 | 0.50 |
Activation time, msec | −31±18 | −28±7 | 0.66 |
Matching pace map, n (%) | 22 (71) | 2 (22) | 0.02 |
RF induced arrhythmias, n (%) | 27 (87) | 9 (100) | 0.56 |
Number of RF application, n | 27±22 | 42±19 | 0.08 |
Total RF duration, min | 22±14 | 33±9 | 0.03 |
Procedure time, min | 305±90 | 387±110 | 0.03 |
Values are means±SD. PAP=papillary muscle; PP=Purkinje potential; RF=radiofrequency; PVC=premature ventricular complex; VT=ventricular tachycardia.